SCHEMBL1948554

SCHEMBL1948554

CCCCNC(=O)CN(CCc1ccc(-c2ccccc2OCC(=O)O)cc1)C(=O)OCCCC

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FSHR P23945 1/20 0.48
KDM4E B2RXH2 3/20 0.43
BRS3 P32247 1/20 0.41
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.40
CYSLTR2 Q9NS75 1/20 0.40
CYSLTR1 Q9Y271 1/20 0.40
PTPN1 P18031 1/20 0.39
KMT2A Q03164 3/20 0.39
TSHR P16473 1/20 0.38
RECQL P46063 1/20 0.38
MME P08473 1/20 0.38
MEN1 O00255 1/20 0.38
LTB4R2 Q9NPC1 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3670220 0.86 FSHR (0.50) FSHRALDH1A1LMNAKMT2AMEN1
SCHEMBL1948540 0.84 FSHR (0.46) FSHRKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL1948553 0.81 KDM4E (0.43) FSHRKDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL1950757 0.78 MEN1 (0.49) FSHRKDM4ELMNAHTTKMT2A
SCHEMBL1950346 0.75 PTGDR2 (0.47) FSHRPTGDR2PTPN1LTB4R2
SCHEMBL1947892 0.73 FFAR1 (0.43) KDM4EALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL1946723 0.73 PTGDR2 (0.51) PTGDR2PTPN1LTB4R2
SCHEMBL3671754 0.69 FSHR (0.47) FSHRALDH1A1KMT2AMEN1HPGD
SCHEMBL2572335 0.67 ALDH1A1 (0.59) KDM4EALDH1A1SMN1; SMN2LMNAHTT
SCHEMBL5112506 0.67 TDP1 (0.48) ALDH1A1LMNAKMT2ATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110136877-A1 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS LIGAND PHARMACEUTICALS INC. (US) 2011-06-09 US disclosed
US-20110136877-A1 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS LIGAND PHARMACEUTICALS INC. (US) 2011-06-09 US disclosed
US-20110136877-A1 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS LIGAND PHARMACEUTICALS INC. (US) 2011-06-09 US disclosed
WO-2009089192-A1 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS LIGAND PHARMACEUTICALS INC. (US) 2009-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136877-A1 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERS HCAR2, PAH, PTGES2 FSHR 2819/4885KDM4E 3400/4885BRS3 4050/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.